Association between cognitive impairment and oral anticancer agent use in older patients with metastatic renal cell carcinoma-Reference-Cited by-同舟云学术

Association between cognitive impairment and oral anticancer agent use in older patients with metastatic renal cell carcinoma

Published:2022-05-02 Issue:8 Volume:70 Page:2330-2343
ISSN:0002-8614
Container-title:Journal of the American Geriatrics Society
language:en
Short-container-title:J American Geriatrics Society

Author:

Pritchard Jessica E.¹^ORCID,Wilson Lauren E.¹^ORCID,Miller Samuel M.²³^ORCID,Greiner Melissa A.¹^ORCID,Cohen Harvey Jay⁴,Kaye Deborah R.⁵^ORCID,Zhang Tian⁶⁷,Dinan Michaela A.⁸⁹^ORCID

Affiliation:

1. Department of Population Health Sciences Duke University Durham North Carolina USA

2. National Clinician Scholars Program Yale University New Haven Connecticut USA

3. Department of Surgery Yale University New Haven Connecticut USA

4. Center for the Study of Aging and Human Development Duke University Durham North Carolina USA

5. Department of Surgery, Division of Urology Duke University Durham North Carolina USA

6. Division of Medical Oncology, Department of Medicine Duke University Durham North Carolina USA

7. Division of Hematology and Oncology, Department of Internal Medicine UT Southwestern Medical Center Dallas Texas USA

8. Department of Chronic Disease Epidemiology Yale School of Public Health New Haven Connecticut USA

9. Yale Cancer Outcomes Public Policy, and Effectiveness Research Center New Haven Connecticut USA

Funder

National Cancer Institute

National Center for Advancing Translational Sciences

Publisher

Wiley

Subject

Geriatrics and Gerontology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgs.17826

Reference81 articles.

1. Epidemiology of Renal Cell Carcinoma

2. Cancer statistics, 2022

3. Kidney cancer NCCN evidence blocks version 1. 2022. NCCN Clinical Practice Guidelines in Oncology: National Comprehensive Cancer Network;2021.

4. Cancer Statistics, 2021

5. Overall survival improvement in patients with metastatic clear-cell renal cell carcinoma between 2000 and 2020: a retrospective cohort study